MarketPeel
Pricing
…
Chief R&D Officer
Jonathan Zalevsky
Sun, May 15, 2022
May 15
received an award in NKTR
23,950 shares @ $0.00
Increased holdings by +8.70%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
NKTRNEKTAR THERAPEUTICS
Health CarePharmaceuticals
1D0.00%
1W+0.07%
1M+4.18%
3M+12.68%
6M—
1Y—

Recent insider activity at NKTR

Aug 18Jonathan ZalevskySold$13.39kAug 18Howard W. RobinSold$30.09kJun 30Jonathan ZalevskySold$397.67kJun 17Howard W. RobinSold$277.43kJun 17Howard W. RobinSold$334.45kJun 16Howard W. RobinSold$285.15kJun 16Howard W. RobinSold$318.02kJun 15Jonathan ZalevskySold$336.21k
Full NKTR profile →Jonathan Zalevsky’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback